Methylphenidan en es it fr

Methylphenidan Brand names, Methylphenidan Analogs

Methylphenidan Brand Names Mixture

  • No information avaliable

Methylphenidan Chemical_Formula


Methylphenidan RX_link

Methylphenidan fda sheet

Methylphenidan FDA

Methylphenidan msds (material safety sheet)

Methylphenidan MSDS

Methylphenidan Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Methylphenidan Molecular Weight

233.306 g/mol

Methylphenidan Melting Point


Methylphenidan H2O Solubility


Methylphenidan State


Methylphenidan LogP


Methylphenidan Dosage Forms

Tablets; Tablets (sustained release)

Methylphenidan Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Methylphenidan Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Methylphenidan Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Methylphenidan side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Methylphenidan Patient Information

Methylphenidan Organisms Affected

Humans and other mammals